-
Product Insights
Administrative Services Auger #2 Mine
The Administrative Services Auger #2 Mine is a coal mine in United States. It is currently in operation. Empower your strategies with our Administrative Services Auger #2 Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and...
-
Product Insights
Administrative Services Auger #3Â Mine
The Administrative Services Auger #3Â Mine is a coal mine in United States. It is currently in operation. Empower your strategies with our Administrative Services Auger #3Â Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons...
-
Product Insights
Natl Def Canada – Bagotville Air Force Base Administrative Facility – Quebec
The Natl Def Canada – Bagotville Air Force Base Administrative Facility – Quebec project involves the construction of a 15,000m2, Air Force training facility in Quebec, Canada. Equip yourself with the essential tools needed to make informed and profitable decisions with our Natl Def Canada – Bagotville Air Force Base Administrative Facility – Quebec report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the...
-
Product Insights
Tokmanni Administration and Logistics Centre Solar PV Park
Tokmanni Administration and Logistics Centre Solar PV Park is a solar PV project located in Uusimaa, Finland. The project came online in 2018. Empower your strategies with our Tokmanni Administration and Logistics Centre Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Analyst Opinions
NewNew Prescription – Generative AI Meets Healthcare (Vol. 2)
Generative Artificial Intelligence (AI) in Healthcare Report Overview GenAI is generating considerable buzz within the healthcare sector, from news updates to deal negotiations and company filings primarily to drive down costs and optimize administrative workflows, promising better healthcare. From accelerating R&D to easing administrative tasks and creating personalized patient experiences, genAI innovations have now proliferated across all the major healthcare application areas. The ’Generative Artificial Intelligence (AI) in Healthcare’ research report is a compendium of the latest real-world innovations in...
-
Sector Analysis
NewPeru Statutory and Private Employee Benefits, 2024 Update
Peru Statutory and Private Employee Benefits Overview The social security system in Peru is undergoing significant change. The informal nature of the labor market is the reason for low social security contributions. Most workers are self-employed and there are lack of information and valuation within the system. In the early 1990s, the social security system established the Sistema Privado de Pensiones (private pension system, or SPP) to provide benefits in the event of old age, disability, and death. This was...
-
Sector Analysis
NewRetinitis Pigmentosa (RP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Retinitis Pigmentosa (RP) Marketed and Pipeline Drugs Report Overview Retinitis pigmentosa (RP) is a cluster of rare eye conditions. One of these conditions causes degeneration of the retina, the light-sensitive layer at the back of the eye. This degeneration results in a progressive loss of vision. Retinitis pigmentosa is an inherited genetic disorder. Most people have progressive vision loss over time, with symptoms usually starting in childhood. While there isn't a cure at this time, people can maximize their residual...
-
Sector Analysis
NewPeripheral Artery Disease (PAD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Peripheral Artery Disease Marketed and Pipeline Drugs Report Overview PAD is an atherosclerotic disease in which the formation of atherosclerotic plaque causes narrowing of the arteries and poor perfusion to the limbs. This can progress to arterial occlusion and chronic limb-threatening ischemia (CLTI). PAD can happen in any blood vessel, but it is more common in the legs than the arms. Key Mechanisms of Action (Marketed) ·      Receptor Agonist ·      Enzyme Inhibitor ·      Biological Factor Activator ·      Ligand Inhibitor ·      ...
-
Company Insights
Innovation and Patenting activity of Link Administration Holdings Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Link Administration Holdings Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will...
-
Sector Analysis
NewResistant Hypertension (RH) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Resistant Hypertension (RH) Marketed and Pipeline Drugs Report Overview Resistant Hypertension (RH) refers to high blood pressure (BP) that is above the target level in a patient. This occurs even when they are taking three different classes of antihypertensive medications concurrently. These medication classes typically include diuretics, long-acting calcium channel blockers, and renin-angiotensin system blockers (ACEs or ARBs). The Resistant Hypertension (RH) marketed, and pipeline drugs research report includes an assessment of the disease epidemiology, leading marketed products with sales...